Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1Phase 1 1

Status

Withdrawn 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Dermatologic 1

Conditions

Leukoplakia, Oral 1Klatskin Tumor 1Keratosis, Actinic 1Healthy Volunteer 1Bile Duct Neoplasms 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2330Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1782Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 935Prednisone 925Cetuximab 921Lenalidomide 916Trastuzumab 901

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Photosensitizing Agents × Clear all
NCT07453472 2026-03-06

PDT CALCI HOL

All India Institute of Medical Sciences

Phase 3 Not yet recruiting
166 enrolled
Head & Neck

Leukoplakia, Oral

NCT05551299 2025-03-27

CARP

University of Leipzig

Phase 4 Recruiting
258 enrolled
Gastrointestinal

Bile Duct Neoplasms, Klatskin Tumor

NCT00756288 2021-12-06

Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses

Northwestern University

Phase NA Withdrawn
Dermatologic

Keratosis, Actinic

NCT02947854 2019-08-28

Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant

PCI Biotech AS

Phase 1 Completed
96 enrolled

Healthy Volunteer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡